The article discusses the beginning of the sale process for BioNTech, with Moderna reportedly seeking to acquire German works.
Bias read (Center): The article reports on business developments involving pharmaceutical companies without apparent ideological framing or biased language. It does not take a stance on the transaction or its implications.